Design of a Fabrication‐Tolerant Directional Coupler via Robust Bayesian Optimization
Electronics Letters · 2026-01 · 62 (1)
DOI: 10.1049/ell2.70557 ↗Kurz gefasst
Fachartikel in der Zeitschrift Electronics Letters, online erschienen am 27.02.2026. Verfasst von Thijs Ullrick und 4 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
The performance of silicon photonic devices is highly sensitive to fabrication‐induced deviations in waveguide core dimensions from their design values. This motivates the development of optimization algorithms that explicitly account for such uncertainties and can identify robust designs, that is, designs whose performance is insensitive to fabrication‐induced variations. In this work, a novel scheme based on robust Bayesian optimization (RBO) is proposed, which leverages well‐established robustness measures and aims to minimize deviations from nominal performance under input uncertainty. The study focuses on an S‐bend directional coupler (DC), but the proposed methodology is general and can be applied to a wide range of passive and active photonic components.
Förderung
- Fonds Wetenschappelijk Onderzoek
Zitieren
APA
Ullrick, T., Liu, Y., Qingy, J., Bogaerts, W., & Dhaene, T. (2026). Design of a Fabrication‐Tolerant Directional Coupler via Robust Bayesian Optimization. Electronics Letters, 62(1). https://doi.org/10.1049/ell2.70557
Vancouver
Ullrick T, Liu Y, Qingy J, Bogaerts W, Dhaene T. Design of a Fabrication‐Tolerant Directional Coupler via Robust Bayesian Optimization. Electronics Letters. 2026;62(1). doi:10.1049/ell2.70557
BibTeX
@article{Ullrick2026,
author = {Ullrick, Thijs and Liu, Yichen and Qingy, Jixiang and Bogaerts, Wim and Dhaene, Tom},
title = {Design of a Fabrication‐Tolerant Directional Coupler via Robust Bayesian Optimization},
journal = {Electronics Letters},
year = {2026},
volume = {62},
number = {1},
doi = {10.1049/ell2.70557}
}
EUVIMED